Multi-receptor agonist / antagonist - AI proteins
Latest Information Update: 10 May 2024
At a glance
- Originator AI Proteins
- Class Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Metabolic disorders
Most Recent Events
- 03 Apr 2024 Early research in Metabolic disorders in USA (Parenteral) (AI proteins pipeline, April 2024)